<SEC-DOCUMENT>0001190725-16-000306-index.html : 20160126
<SEC-HEADER>0001190725-16-000306.hdr.sgml : 20160126
<ACCEPTANCE-DATETIME>20160126153731
ACCESSION NUMBER:		0001190725-16-000306
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20160122
FILED AS OF DATE:		20160126
DATE AS OF CHANGE:		20160126

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Mirati Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001576263
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				462693615
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		9393 TOWNE CENTRE DRIVE
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-332-3410

	MAIL ADDRESS:	
		STREET 1:		9393 TOWNE CENTRE DRIVE
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Gergen Mark J
		CENTRAL INDEX KEY:			0001373110

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35921
		FILM NUMBER:		161361465

	MAIL ADDRESS:	
		STREET 1:		9360 TOWNE CENTRE DR
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>